As of 2025-09-18, the Fair Value of 10X Genomics Inc (TXG) is -3.40 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 12.86 USD, the upside of 10X Genomics Inc is -126.42%.
With the market price of 12.86 USD and our fair value calculation, 10X Genomics Inc (TXG) is not a good investment. Investing in TXG stocks now will result in a potential loss of 126.42%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -542.70 | -58.20 | -166.00 | -255.10 | -182.63 | -240.93 |
| YoY growth | -1,633.87% | 89.28% | -185.22% | -53.67% | 28.41% | -351.02% |
| Market Cap (mil) | 1,600.94 |
| P/E | |
| Forward P/E |
| EPS | -0.68 |
| Avg earnings growth rate | -351.02% |
| TTM earnings | -84.60 |